Synonyms |
(-)-Epigallocatechin gallate; EGCG; 989-51-5; Epigallocatechin gallate; Epigallocatechin 3-gallate; Tea catechin; Epigallocatechin-3-gallate; Teavigo; Epigallocatechin-3-monogallate; (-)-Epigallocatechin-3-o-gallate; (-)-epigallocatechin 3-gallate; PF-EGCg 90; (-)-Epigallocatechol gallate; NVP-XAA 723; CCRIS 3729; (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxybenzoate; Catechin deriv.; UNII-BQM438CTEL; BQM438CTEL; epigallocatechin-3-O-gallate; CHEBI:4806; Epigallocatechingallate; Epigallocatechin-gallate; Epigallocatechol, 3-gallate, (-)-; (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate; CHEMBL297453; [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate; DTXSID1029889; [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate; Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester; EGCG cpd; (-)-Epigallocatechin Gallate (Standard); (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate; Gallic acid, 3-ester with epigallocatechol, (-)-; DTXCID80567; (-)-cis-3,3',4',5,5',7-Hexahydroxy-flavane-3-gallate; epigallo-catechin gallate; (-)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate; Benzoic acid, 3,4,5-trihydroxy-, 3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester, (2R-cis)-; Benzoic acid, 3,4,5-trihydroxy-,(2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester; CAS-989-51-5; SMR000449288; SR-01000759328; (-)-EPIGALLOCATECHIN-3-O-GALLATE (USP-RS); (-)-EPIGALLOCATECHIN-3-O-GALLATE [USP-RS]; L-Epigallocatechin gallate; Epigallocate; Sunphenon; EPIGALOCATECHIN GALLATE; (-)-EGCG; Epigallocic acid; Teatannin II; 2kdh; 3oob; 4awm; (-)-epigallocatechin 3-O-gallate; KDH; Epigallocatcchin Gallate; Epigallocatechol Gallate; Spectrum_000316; SpecPlus_000277; Spectrum2_000168; Spectrum3_000244; Spectrum4_001541; Spectrum5_000102; Galloyl-L-epigallocatechol; EGCG [WHO-DD]; EGCG [MI]; 3-O-Galloylepigallocatechin; (-)-Epigallocatechin gallat; (-)-Epigallocatehin gallate; SCHEMBL35258; BSPBio_001628; epigallocatechin-gallate-(-); KBioGR_002002; KBioSS_000796; SPECTRUM210239; cid_65064; MLS000758300; MLS001424000; DivK1c_006373; SPBio_000035; Epigallocatechin monogallate, B; GTPL7002; MEGxp0_001166; (-)-Epigallocatechin-3-gallate; ACon1_001054; KBio1_001317; KBio2_000796; KBio2_003364; KBio2_005932; KBio3_001128; HMS2051K21; HMS3649E08; 3-O-Galloyl-(-)-epigallocatechin; EPIGALLOCATECHIN 3-O-GALLATE; Tox21_201468; Tox21_303457; BDBM50070942; CCG-38378; FR-109; HY-13653R; LMPK12030005; MFCD00075940; s2250; AKOS015918182; CS-1258; DB12116; DS-9030; EPIGALLOCATECHIN GALLATE [INCI]; MCULE-3341525983; MCULE-7760530136; NC00078; SDCCGMLS-0066550.P001; (-)-Epigallocatechin gallate, >=95%; (-)-Epigallocatechin-3-gallate; EGCG; NCGC00164319-01; NCGC00164319-02; NCGC00164319-03; NCGC00164319-04; NCGC00164319-06; NCGC00257243-01; NCGC00259019-01; (-)-Epigallocatechin gallate (85% (-)-epigallocatechin gallate, 10% (-)-epigallocatechin, 5% (-)- epicatechin gallate); 1ST40118; AC-34075; BP-30205; HY-13653; CS-0694875; E0694; NS00015163; SW197458-3; C09731; M01719; (-)-Epigallocatechin gallate, >=97.0% (HPLC); (-)-Epigallocatechin gallate, analytical standard; A845931; Q393339; SR-01000946601; Q-100914; SR-01000759328-5; SR-01000759328-6; SR-01000946601-1; Epigallocatechin-3-gallate 1000 microg/mL in Acetonitrile; (-)-Epigallocatechin gallate, >=80% (HPLC), from green tea; Epigallocatechin gallate, primary pharmaceutical reference standard; ((2R,3R)-2-(3,4,5-trihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl) 3,4,5-trihydroxybenzoate; (-)-Epigallocatechin-3-O-gallate, United States Pharmacopeia (USP) Reference Standard; (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl3,4,5-trihydroxybenzoate; [5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 2,3,4-trihydroxybenzoate; Epigallocatechin gallate, Pharmaceutical Secondary Standard; Certified Reference Material; (-)-cis-3,4-Dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-1(2H)-benzopyran-3-yl Gallate; (-)-EPIGALLOCATECHIN GALLATE (85% (-)-EPIGALLOCATECHIN GALLATE, 10% (-)-EPIGALLOCATECHIN, 5% (-)-EPICATECHIN GALLATE); (-)-EPIGALLOCATECHIN-3-O-GALLATE (EGCG) (CONSTITUENT OF POWDERED DECAFFEINATED GREEN TEA EXTRACT); (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl-3,4,5-trihydroxybenzoate; (2R-cis)-3,4-Dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl 3,4,5-Trihydroxybenzoate; [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl]3,4,5-trihydroxybenzoate; 2041570-28-7; 3,4-Dihydro-5,7-dihydroxy-2R-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3R-yl-3,4,5-trihydroxybenzoate
|